Skip to content

Insider · CIK 0001016157

Mark T Hilz

officerdirectorcoo

Files at HSCS (HeartSciences Inc.). First filing Jul 30, 2025, latest Jul 30, 2025.

In brief

Mark T Hilz files SEC Form 4 as director and COO at HSCS (HeartSciences Inc.). Since Jul 30, 2025, Mark T Hilz has reported 0 open-market buys worth $0 and 1 open-market sell worth $16k, the latest filed on Jul 30, 2025.

A track record needs three past buys with six months of prices behind them; Mark T Hilz has 0, so none is measured yet.

The newest scored trade: sold $16k of HSCS on Jul 29, 2025, filed Jul 30, 2025, scored 10 (weak), under a 10b5-1 plan.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $16k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

HSCS: HeartSciences Inc.

HSCSOct 9, 2026 · close 3.18

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
10Weak
HSCSsell10b5-1
HeartSciences Inc.
$16k
4,416 shares
-48%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jul 29, 2025 HSCS
HeartSciences Inc.
4,416
0.23% of outstanding
$16kJul 29, 2025none

Transactions

Every row this insider has filed, 5 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 22, 2025HSCS
HeartSciences Inc.
AGrant or award
Restricted Stock Unitsderivative
+45,000$0.00$045,000Dec 22, 2025
Jul 29, 2025HSCS
HeartSciences Inc.
SOpen-market sale
Common Stock, $0.001 par value10b5-1
-4,416$3.54$16k4,752Jul 30, 2025
Jul 9, 2025HSCS
HeartSciences Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+225,000--225,000Jul 11, 2025
Jul 9, 2025HSCS
HeartSciences Inc.
AGrant or award
Restricted Stock Unitsderivative
+56,250$0.00$056,250Jul 11, 2025
Jan 16, 2025HSCS
HeartSciences Inc.
AGrant or award
Employee Stock Option (Right to Buy)derivative
+45,000--45,000Jan 21, 2025

Questions about Mark T Hilz

Answered from the filings on this page, as of the latest one.

Is Mark T Hilz buying or selling?

Not in the last 12 months. Mark T Hilz's latest open-market trade on SEC Form 4 was sold $16k of HSCS on Jul 29, 2025.

How did Mark T Hilz's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark T Hilz has 0.

Where does Mark T Hilz file Form 4?

Mark T Hilz has filed Form 4 at HSCS (HeartSciences Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mark T Hilz: insider trades and track record | InsiderTell